| Title : Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob\/ob mice - Moritoh_2008_Eur.J.Pharmacol_588_325 |
| Author(s) : Moritoh Y , Takeuchi K , Asakawa T , Kataoka O , Odaka H |
| Ref : European Journal of Pharmacology , 588 :325 , 2008 |
| Abstract : Moritoh_2008_Eur.J.Pharmacol_588_325 |
| ESTHER : Moritoh_2008_Eur.J.Pharmacol_588_325 |
| PubMedSearch : Moritoh_2008_Eur.J.Pharmacol_588_325 |
| PubMedID: 18499100 |
Moritoh Y, Takeuchi K, Asakawa T, Kataoka O, Odaka H (2008)
Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob\/ob mice
European Journal of Pharmacology
588 :325
Moritoh Y, Takeuchi K, Asakawa T, Kataoka O, Odaka H (2008)
European Journal of Pharmacology
588 :325